Cardinal/Syncor try to save merger
Executive Summary
Cardinal Health and Syncor begin merger re-negotiations following Syncor's announcement of potential "questionable payments" to customers in Taiwan and other countries (1"The Pink Sheet" Nov. 11, In Brief)...
You may also be interested in...
Cardinal’s Syncor acquisition on hold
"There can be no assurance that the transaction involving the acquisition of Syncor by Cardinal Health will be completed," the drug wholesaler said Nov. 6. Cardinal's due diligence investigation discovered "improper payments that had been made in foreign countries by subsidiaries of Syncor," the company said. Cardinal announced its merger agreement with the nuclear pharmacy company in June (1"The Pink Sheet" June 17, p. 9)...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.